IL315890A - Treatment of mental disorders - Google Patents
Treatment of mental disordersInfo
- Publication number
- IL315890A IL315890A IL315890A IL31589024A IL315890A IL 315890 A IL315890 A IL 315890A IL 315890 A IL315890 A IL 315890A IL 31589024 A IL31589024 A IL 31589024A IL 315890 A IL315890 A IL 315890A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- mental disorders
- mental
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22000086 | 2022-03-27 | ||
| EP22000083 | 2022-03-27 | ||
| EP23153939 | 2023-01-30 | ||
| EP23153995 | 2023-01-30 | ||
| PCT/EP2023/057883 WO2023186835A1 (en) | 2022-03-27 | 2023-03-27 | Treatment of mental disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315890A true IL315890A (en) | 2024-11-01 |
Family
ID=93292079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315890A IL315890A (en) | 2022-03-27 | 2023-03-27 | Treatment of mental disorders |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250241894A1 (enExample) |
| EP (1) | EP4499086A1 (enExample) |
| JP (1) | JP2025510911A (enExample) |
| KR (1) | KR20250005172A (enExample) |
| AU (1) | AU2023246680A1 (enExample) |
| CA (1) | CA3255635A1 (enExample) |
| IL (1) | IL315890A (enExample) |
-
2023
- 2023-03-27 US US18/850,394 patent/US20250241894A1/en active Pending
- 2023-03-27 JP JP2024557189A patent/JP2025510911A/ja active Pending
- 2023-03-27 EP EP23717047.7A patent/EP4499086A1/en active Pending
- 2023-03-27 CA CA3255635A patent/CA3255635A1/en active Pending
- 2023-03-27 IL IL315890A patent/IL315890A/en unknown
- 2023-03-27 AU AU2023246680A patent/AU2023246680A1/en active Pending
- 2023-03-27 KR KR1020247035656A patent/KR20250005172A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250241894A1 (en) | 2025-07-31 |
| CA3255635A1 (en) | 2023-10-05 |
| AU2023246680A1 (en) | 2024-11-07 |
| EP4499086A1 (en) | 2025-02-05 |
| KR20250005172A (ko) | 2025-01-09 |
| JP2025510911A (ja) | 2025-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202212876B (en) | 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders | |
| IL288214A (en) | Quinazolin-4-one derivatives are useful for the treatment of braf-related diseases and disorders | |
| IL309317A (en) | Treatment of diseases and disorders associated with MTRES1 | |
| IL287280A (en) | Compounds and methods for the treatment of ocular disorders | |
| IL315898A (en) | Anxiety treatment | |
| IL313920A (en) | Treatment of heart and lung disorders | |
| IL287264A (en) | Compounds and methods for the treatment of ocular disorders | |
| GB201914034D0 (en) | Treatment of neurological disorders | |
| IL304628A (en) | Treatment of skin disorders | |
| IL315890A (en) | Treatment of mental disorders | |
| IL319571A (en) | R-Trihexyphenidyl for the treatment of movement disorders | |
| LT4313114T (lt) | Kombinuotas smegenų traumos gydymas | |
| EP4355355A4 (en) | TREATMENT OF PLIN1-ASSOCIATED DISEASES AND DISORDERS | |
| GB202001353D0 (en) | Treatment of skin conditions | |
| IL321120A (en) | Treatment of mtres1-related diseases and disorders | |
| GB202007054D0 (en) | Treatment of lipid disorders | |
| CA3287339A1 (en) | Advantageous fluorobenzofurans for the treatment of mental disorders or enhancement | |
| GB201904717D0 (en) | Treatment and diagnosis of mental disorders | |
| CA3282838A1 (en) | Piperazine-substituted benzothiophenes for treatment of mental disorders | |
| IL315909A (en) | Gene therapy for the treatment of cognitive disorders | |
| GB202416895D0 (en) | Treatment of sleep disorders | |
| GB202104753D0 (en) | Treatment of ophthalmological conditions | |
| HK40104631A (en) | Treatment of skin disorders | |
| GB202307686D0 (en) | Treatment of conditions | |
| GB202315695D0 (en) | TReatment of cariomyopathy |